Germany Clinical Trial Supplies Market Size & Outlook

The clinical trial supplies market in Germany is expected to reach a projected revenue of US$ 228.0 million by 2030. A compound annual growth rate of 6.9% is expected of Germany clinical trial supplies market from 2024 to 2030.
Revenue, 2023 (US$M)
$142.7
Forecast, 2030 (US$M)
$228.0
CAGR, 2024 - 2030
6.9%
Report Coverage
Germany

Germany clinical trial supplies market, 2018-2030 (US$M)

Germany

Germany clinical trial supplies market highlights

  • The Germany clinical trial supplies market generated a revenue of USD 142.7 million in 2023 and is expected to reach USD 228.0 million by 2030.
  • The Germany market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase III is the most lucrative phase segment registering the fastest growth during the forecast period.


Clinical trial supplies market data book summary

Market revenue in 2023USD 142.7 million
Market revenue in 2030USD 228.0 million
Growth rate6.9% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase III
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III
Key market players worldwideAlmac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair


Other key industry trends

  • In terms of revenue, Germany accounted for 5.5% of the global clinical trial supplies market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK clinical trial supplies market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 228.0 million by 2030.

Phase iii was the largest segment with a revenue share of 53.82% in 2023. Horizon Databook has segmented the Germany clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.


Germany is one of the major sites for clinical trials along with the UK in Europe. Advancements in technology and availability of high-quality clinical resources are some of the main factors responsible for the growth of this market.

High overhead cost is a major challenge, hence, developing countries are being considered for this market. Clinical supplies providers such as PAREXEL International Corporation dominate the market.

In 2014, PAREXEL International Corporation opened a new distribution center and coordination hub in Berlin, Germany to expand its access to European countries and provide support to clinical trials conducted in Germany.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Supplies Market Companies

Name Profile # Employees HQ Website

Germany clinical trial supplies market size, by phase, 2018-2030 (US$M)

Germany Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)

Germany clinical trial supplies market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more